Search results
Results from the WOW.Com Content Network
Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. [1] It was founded in 2008 by Osman Kibar. [2] Samumed's products in development target novel components of the Wnt signaling pathway.
Arena Pharmaceuticals Inc. is an American biopharmaceutical company founded in 1997 and headquartered in San Diego, California. Arena focused on discovering drugs that act on G protein-coupled receptors (GPCRs). The company developed technology it called Constitutively Activated Receptor Technology (CART) that identified drug leads targeting ...
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Top companies in the San Diego metro area on the 2012 Inc. 5000 This page was last edited on 23 January 2025, at 00:20 (UTC). Text is available under the Creative ...
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. [1] It is headquartered in San Diego, California, and led by CEO Kevin Gorman. [3] Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.
Scripps Research is a nonprofit American medical research facility that focuses on research and education in the biomedical sciences.Headquartered in San Diego, California, the institute has over 170 laboratories employing 2,100 scientists, [1] technicians, graduate students, and administrative and other staff.
In 1987, Amylin Pharmaceuticals was co-founded by Howard E. Greene Jr., former CEO of San Diego biotech pioneer Hybridtech, to develop a treatment for diabetes from a synthetic analog of amylin. [3] Amylin was discovered by researchers at Oxford University earlier that year. [4] Greene served as CEO from 1987 to 1996. Amylin completed its IPO ...